News

Arcus Hunting, LLC, USA, the maker of Tink’s and Dead Down Wind hunting scents, announced a new licensing partnership to ...
Arcus Biosciences’ quemliclustat receives US FDA orphan drug designation to treat pancreatic cancer: Hayward, California Tuesday, July 15, 2025, 13:00 Hrs [IST] Arcus Bioscience ...
The FDA has granted orphan status to Arcus Biosciences’ CD73 inhibitor quemliclustat for metastatic pancreatic cancer, as the ...
Arcus will host a conference call today to discuss the ARC-20 results and casdatifan development plans at 5:00 AM PT / 8:00 AM ET; February 18, 2025 06:57 AM Eastern Standard Time.
Arcus senilis is when you have a white or gray ring or arc around your cornea. Learn more about what causes it, symptoms of arcus senilis, and more.
Arcus Forward-Looking Statements. This press release contains forward-looking statements. All statements regarding events or results to occur in the future contained herein are forward-looking ...
Arcus Biosciences, Inc. (NYSE:RCUS), a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies for patients with cancer, today ...
Arcus Biosciences announced that the Food and Drug Administration has granted its pancreatic cancer treatment, quemliclustat, with an orphan drug designation. The company said it expects its ongoing ...